Evotec’s Post

🚀 New customer case study alert! 🚀 🌐💡The recent work of Valentina Paloschi and her collaborators showcasing Fluigent’s Microfluidic Flow Control System is truly groundbreaking! 🩸By ingeniously creating an Artery-on-chip model, they've successfully replicated the structure of medium-to-large size arteries and deciphered their response to hemodynamic forces. 💊The AoC model not only mimics arteries but also serves as an advanced platform for predictive drug testing, offering insights into the effects of therapeutic agents used in preclinical studies! 🔍Read more about this exciting research here: https://bit.ly/3UT1oaE #Microfluidics #BiotechInnovation #DrugDiscovery #ScienceAdvancement

Culture Biosciences’ cloud-connected, high-throughput bioreactor platform can reproducibly process and optimize CHO cell culture experiments with scalable results. Data presented in this white paper by engineers in Culture’s Cloud Lab demonstrate upstream bioprocesses to develop, optimize and scale cell culture processes. With access to significant bioreactor capacity leveraging advanced analytical software to generate insights faster, clients working with Culture can spend their time focusing on what matters most: developing critical therapeutics for the patients who need them. #processdevelopment #processoptimization #mAb #CHO https://lnkd.in/eqghbyz4

Next Generation Sequencing (NGS) Market is growing at a CAGR of 20.4 % during the forecast period 2024-2031 For More Insights: https://lnkd.in/gHpeVPbZ Thermo Fisher Scientific | Agilent Technologies | Bio-Rad Laboratories | Roche | Revvity | Illumina | PacBio | DNASTAR | BGI Group | QIAGEN

Interested in cloud-connected upstream process development and optimization. Learn more by downloading Culture Biosciences’ white paper. #cloudconnectivity #processdevelopment #bioreactor #bioprocess

🎥 Behind the scenes at evitria! Ever wondered what goes on at the heart of our antibody production process? Now’s your chance to take an exclusive look! In this video, created in cooperation with our trusted supplier Bio-Rad, we share insights into evitria’s manufacturing site, where we’ve grown from pioneering CHO cell expression to becoming a fully integrated service provider. With over 35 NGc systems, our new facility is designed to support the production of complex antibodies, including multi-specifics, at the highest quality standards. Watch the video to see how we’re pushing the boundaries of antibody engineering and continuously optimizing for speed, efficiency, and precision. Here is the link to the video: #AntibodyDevelopment #Biotechnology #CHOCellExpression #ManufacturingInnovation #evitria #BioRad #AntibodyEngineering

Why are #organoids becoming increasingly popular in drug discovery, and how can you integrate these powerful cell models into your research? Our Essential Guide to Organoids in Drug Discovery is your go-to resource. It covers the history, current role, and future impact of organoids in drug discovery. You'll discover how organoids can be used across various applications and how new technologies are breaking down barriers to using these models in the #drugdiscovery process. Read more: https://lnkd.in/eE5jYpyE

CryoEM captures protein structures with unmatched precision, providing the data essential to designing effective protein-based therapeutics. In our latest blog, Edward Brignole, Head of CryoEM, describes this technology as “the eyes” of our design-build-measure-learn cycle, enabling us to visualize molecules in their native state. #CryoEM produces the high-resolution data needed to drive structure-informed drug development. By transforming CryoEM into a high-throughput tool, #TeamGenerate is pushing the boundaries of what’s possible in therapeutic development. With four state-of-the-art microscopes in our Andover lab, we’re unlocking new dimensions in drug discovery. Read how CryoEM is reshaping our approach to therapeutic design: https://lnkd.in/eKSdq5Jd #GenerativeAI | #ProgrammingBiology

Culture Biosciences’ cloud-connected, high-throughput bioreactor platform can reproducibly process and optimize CHO cell culture experiments with scalable results. Data presented in this white paper by engineers in Culture’s Cloud Lab demonstrate upstream bioprocesses to develop, optimize and scale cell culture processes. With access to significant bioreactor capacity leveraging advanced analytical software to generate insights faster, clients working with Culture can spend their time focusing on what matters most: developing critical therapeutics for the patients who need them. #processdevelopment #processoptimization #mAb #CHO https://lnkd.in/eqghbyz4

[Lonza Webinar] Leveraging Targeted Integration for Efficient Screening in CHO Cells To efficiently engineer cell models, such as CHO cells, for drug discovery, it is crucial to use a reliable transfection method. In addition, high throughput transfection and the possibility for automation are key for successful screening setups. The webinar includes a Q&A session and will last approximately 30 minutes. Unable to attend? Register now and receive an email notification as soon as the event is available for on-demand viewing. Save The Date: 📅 Tuesday, 10 December 2024 🕓 15.00 WIB (9:00 AM CET) ✍ Registration: https://bit.ly/chowebinar 📃 For more info please see the flyer or visit the registration link #GeneCraftLabs #TrustedPartnerforLaboratorySolution #QIAGEN #webinar #freewebinar #CHOcells #drugdiscovery #cell #transfection #proteintherapeutics

Life Sciences-This Week: December 6, 2024 ·  Strategic Acquisition: GeminiBio and Bio-Techne ·  Roche Acquires Poseida Therapeutics, Inc. in $1.5 Billion Deal ·  GE HealthCare to Fully Acquire Nihon Medi-Physics Co., Ltd. ·  10x Genomics and Hamilton Company Boost Single Cell Research ·  Tagomics and Agilent Technologies Forge Co-Marketing Alliance ·  Sartorius Stedim Biotech Unveils Innovation Center in Marlborough ·  QIAGEN Innovates with Custom Tools for Microbial Analysis SUBSCRIBE to be notified of new episodes and watch prior episodes. https://lnkd.in/gkgVPgUs #LifeSciences #News #Boston #Pharma